Orrstown Finl Servs (NASDAQ:ORRF) reported quarterly earnings of $0.76 per share. This is a 17.39 percent decrease over earnings of $0.92 per share from the same period last year.
Vallon Pharmaceuticals Granted European Patent Titled ‘ABUSE DETERRENT FORMULATIONS OF AMPHETAMINE (FOR THE TREATMENT OF PSYCHIATRIC DISORDERS INCLUDING ATTENTION-DEFICIT/HYPERACTIVITY DISORDER)’
https://data.epo.org/publication-server/pdf-document?pn=3943066&ki=B1&cc=EP